@article{JLPM3729,
author = {Reginald M. Gorczynski},
title = {Role for expression of CD200 in multiparameter flow cytometric differential diagnosis of mature B-cell neoplasms},
journal = {Journal of Laboratory and Precision Medicine},
volume = {2},
number = {8},
year = {2017},
keywords = {},
abstract = {This issue of the journal includes an important study by Sandes et al. (1), which explores whether inclusion of analysis of CD200 expression can contribute to improved classification of mature B cell neoplasms (MBN). Currently, the most frequent subgroupings used for classification purposes are (2,3): CD5+CD10− [(chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)]; CD5−CD10+ [Follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL), and Burkitt’s lymphoma]; and CD5−CD10− [marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma, and lymphomas with hairy/villous cells including splenic marginal zone lymphoma (SMZL), and hairy cell leukemia (HCL)].},
issn = {2519-9005}, url = {https://jlpm.amegroups.org/article/view/3729}
}